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ABSTRACT  
Functionalized colloidal nanoparticles for SERS serve as a promising multifunctional assay component for blood 
biomarker detection. Proper design of these nanoprobes through conjugation to spectral tags, protective polymers, and 
sensing ligands can provide experimental control over the sensitivity, range, reproducibility, particle stability, and 
integration with biorecognition assays. Additionally, the optical properties and degree of electromagnetic SERS signal 
enhancement can be altered and monitored through tuning the nanoparticle shape, size, material and WKHFROORLG¶VORFDO
surface plasmon resonance (LSPR). Aptamers, synthetic affinity ligands derived from nucleic acids, provide a number of 
advantages for biorecognition of small molecules and toxins with low immunogenicity. DNA aptamers are simpler and 
more economical to produce at large scale, are capable of greater specificity and affinity than antibodies, are easily tailored 
to specific functional groups, can be used to tune inter-particle distance and shift the LSPR, and their intrinsic negative 
charge can be utilized for additional particle stability1,2. Herein, a ³WXUQ-RII´competitive binding assay platform involving 
two different plasmonic nanoparticles for the detection of the toxin bisphenol A (BPA) using SERS is presented. A 
derivative of the toxin is immobilized onto a silver coated magnetic nanoparticle (Ag@MNP), and a second solid silver 
nanoparticle (AgNP) is functionalized with the BPA aptamer and a Raman reporter molecule (RRM). The capture 
(Ag@MNP) and probe (AgNP) particles are mixed and the aptamer binding interaction draws the nanoparticles closer 
together, forming an assembly that results in an increased SERS signal intensity. This aptamer mediated assembly of the 
two nanoparticles results in a 100x enhancement of the SERS signal intensity from the RRM. These pre-bound 
aptamer/nanoparticle conjugates were then exposed to picomolar levels of BPA in free solution and the competitive 
binding event was monitored by the decrease in SERS intensity. 
Keywords: Surface enhanced Raman spectroscopy (SERS), aptamer, plasmonic nanoparticles, competitive binding assay, 
molecular diagnostics 
1. INTRODUCTION  
Molecularly mediated surface enhanced Raman spectroscopy (SERS) can be a desirable approach for ultrasensitive blood 
biomarker detection due to its high sensitivity and capability for multiplexing. SERS analysis of DNA-directed 
nanoparticle assembly using functionalized colloidal nanoparticles has been used extensively as a method to measure and 
control the degree of enhancement of Raman scattering from a Raman active dye in response to a molecular binding event3. 
SERS assays LQ ERWK ³WXUQ ±RQ´ DQG ³WXUQ-RII´ IRUPDWV have been developed using oligonucleotides to detect DNA 
fragments4, as well as with aptamers for the detection of biomarker proteins5 ,Q WKLV ZRUN ZHSUHVHQW D ³6(56RII´
competitive binding assay for the detection of BPA: a small molecule toxic to the human endocrine system commonly 
found in food and beverage packaging.  
A schematic representation of the two nanoprobes developed for this assay is shown in Figure 1. TKH µWDUJHW¶ VLOYHU
nanoparticle is functionalized with a mixed self-assembled monolayer consisting of the Raman reporter molecule 
malachite green isothiocyanate (MGICT) and BPA aptamers. These particles are designed to bind to a version of the toxin 
bisphenol A diglycidyl ether (BADGE), immobilized onto a second silver coated magnetic ¶SUREH¶ nanoparticle, where 





events experienced by the Raman reporter that is observable in the SERS spectral intensity. Upon introduction of free BPA 
in its native form, the bound AgNPs are competitively freed; reversing the nanoparticle assembly and causing the SERS 
signal to ³WXUQ-RII´DQG decrease in response to the competitive binding event. 
Figure 1. Top: Schematic illustration of the aptamer mediated µWXUQ-RII¶SERS competitive binding assay. Bottom: Target 
and probe nanoparticle conjugate components. 
 
2. MATERIALS & METHODS 
2.1 Materials and Instrumentation 
The modified BPA aptamer7¶- [ThiSS][HEG]3 CCG CCG TTG GTG TGG TGG GCC TAG GGC CGG CGG CGC 
ACA GCT GTT ATA GAC GTC TCC AGC-¶ZDVV\QWKHVL]HGE\(XURILQV*HQRPLFV*HUPDQ\.  Hetero-bifunctional 
PEG linker (NH2-PEG-SH, 1kDa) was purchased from NanoCS (USA). Malachite green isothiocyanate reporter dye was 
purchased from Invitrogen (UK). All other reagents were obtained from Sigma Aldrich (USA/UK).  
A Varian Cary 300Bio UV-Visible Spectrophotometer was used with a scan range of 200-800 nm for extinction 
measurements. The zeta potential and hydrodynamic diameters of the nanoparticles were measured on a Zetasizer Nano 
ZS90 (Malvern, U.K.). SERS measurements were collected using a WiTec Raman instrument equipped with a 532 nm 
laser. 
2.2 Colloid Synthesis 
Silver colloid (AgNP) was synthesized using the reduction method as reported by Leopold and Lendl8. Hydroxylamine 
hydrochloride (1 ml, 150 mM) was added to 89mL of NaOH (3.33 mM) under vigorous stirring. Silver nitrate (AgNO3) 
solution (10 mM) was added drop-wise and stirred for 15 min at room temperature. DLS measurements revealed an average 
particle diameter of ~45 nm and the stock particle concentration was determined to be 145 S0DFFRUGLQJWR%HHU¶V/DZ
using an extinction coefficient of 2.87 ൈ 1010 M-1 cm-1 at 404 nm. 
Silver-coated magnetic nanoparticles (Ag@MNP) were prepared using a co-precipitation method for the synthesis of the 
particle core and glucose reduction to coat with silver as described by Kumar et al9  and Mandal et al10 respectively. Briefly, 
DVWRFNVROXWLRQRIPDJKHPLWHȖ-Fe2O3) nanoparticles was prepared by adding 25 mL of an acidified iron salt solution 
(0.4 M Fe2+, 0.8 M Fe3+, 1 M HCl) drop-wise to 250 mL of 1.5 M NaOH at 50°C under vigorous non-magnetic stirring. 
After 20 minutes the particles were allowed to cool, washed twice with DI water and once with 0.1M HNO3. An additional 




To coat with silver, 1mL of these stock MNPs was mixed with 4 mL of 0.35 M glucose and 1.5 mL of 60 ʅM AgNO3. The 
solution was sonicated for 10 minutes then heated to 90°C for 90 minutes. Finally, the particles were centrifuged three 
times to wash, and redispersed in 6 mL of 5 mM sodium citrate for a particle diameter of ~31 nm and final concentration 
of 608 pM as previously reported11.  
2.3 Target and Probe Nanoparticle Conjugation 
Aptamer/RRM AgNP Target Synthesis  
Prior to immobilization, the BPA aptamers were suspended in a 60 mM phosphate buffer (PBS, pH 8.5) and treated with 
15 mg of dithiothreitol (DTT) to reduce their disulfide bonds. After one hour the aptamers were HPLC purified to remove 
residual DTT, and then heated to 90°C for 5 minutes to fold the aptamers into their tertiary structure for optimal binding.  
Target AgNPs were functionalized with the aptamer in accordance with the method developed by Zhang et al12. The 
aptamer (7 µM) was added to 1 mL of silver colloid (145 pM) at a molar ratio of 2000:1 and left for 1 hour. Three 20µL 
aliquots of 250 mM citrate HCl buffer (pH 2.9) were then added 5 minutes apart, and the sample was left an additional 30 
minutes before centrifuging and resuspending the aptamer functionalized particles in 1 mL of 0.3 M PBS (pH 7.4). The 
Raman reporter molecule, malachite green isothiocyanate (MGICT, 10 µM in methanol), was then added at a 500:1 ratio 
and left to react with the aptamer AgNPs under sonication for 1 hour, which were then centrifuged and stored in a 0.1 M 
PBS buffer (pH 7.4).  
Analyte Ag@MNP Probe Synthesis 
To synthesize 1 mL of BADGE functionalized magnetic nanoprobes, the SH-PEG-NH2 linker was added drop-wise to an 
excess of the analyte BADGE in 0.3 M PBS buffer (pH 8.5) and left overnight to allow conjugation between their terminal 
amine and epoxide groups respectfully. The conjugates were then treated with aminoethanol to open unbound epoxide 
rings and prevent non-specific binding of BADGE WRWKH550¶VDPLQHJUoups. These SH-PEG-BADGE conjugates were 
then added at a 5000:1 ratio to 1 mL of silver coated magnetic nanoparticles (diluted to 200 pM). After one hour three 
20µL aliquots of 250 mM citrate HCl buffer were again added 5 minutes apart, and the sample was left an additional 30 
minutes before centrifuging and resuspending the BADGE functionalized particles in 1 mL of 0.1 M PBS (pH 7.4). 
2.4 SERS analysis 
Equal volumes containing 30 pM of each of the target and probe nanoparticles were left overnight to allow complete 
binding between the immobilized BPA aptamers and BADGE. The assembled nanoparticle clusters were collected using 
a neodymium magnet held at the side of the glass vial for 30 minutes, the supernatant containing any unbound AgNPs was 
removed, and the assembled nanoparticles were resuspended in 0.1 M PBS (pH 7.4). All SERS measurements were 
collected with the target AgNP concentration held constant at 7.5 pM in a total volume of 30 µL of 0.1 M PBS (pH 7.4) 
with an integration time of 10 seconds (1s exposure). For competitive binding analysis 15 µL of the assembled target/probe 
NPs was mixed with 15 µL of 1 µM BPA in 0.1 M PBS (pH 7.4) and SERS measurements were taken every 30 seconds. 
 
3. RESULTS AND DISSCUSSION 
The target and probe nanoparticles were functionalized as described and yielded average zeta potential measurements of -
39.7 and -34.6 mV respectively, indicating that the PEG spacer and the HEG modified aptamer provide adequate particle 
stabilization in the 0.1 M PBS binding buffer. The intrinsic SERS signal of a stock solution of the the assembled 
nanoparticles and its response to the presence of competing BPA was then analyzed. As shown in Figure 2, the SERS 
signal of the reporter molecule MGICT increases by two orders of magnitude as it experiences an enhancement in the 
electric field intensity of its immediate environment due to the aptamer-binding induced particle aggregation. When free 
BPA is added to the conjugate solution, it is observed that the SERS intensiW\RI0*,&7¶V 1175 cm-1 peak (aromatic C±
H bending vibrational mode13) decreases to a steady state over the course of ~5 min as competitive binding occurs (Fig. 2, 
inset). That is to say, the BPA aptamer immobilized on the target AgNPs releases from the BADGE on the MNPs in order 
to more favorably bind to free BPA, and the released particles return to colloidal suspension causing a decrease in the 




Figure 2. SERS spectra of the target and probe nanoparticles: (1) individually, (2) mixed overnight to allow complete NP 
assembly via aptamer/BADGE binding, and (3) assembled NPs after exposure to 15 pmol of the competing analyte. Inset: 
SERS monitoring of the competitive binding event over 15min.  
 
4. CONCLUSION 
In summary, we have described a ³WXUQ-RII´SERS assay platform methodology for the detection of small toxins utilizing 
aptamer-mediated assembly of SERS active colloidal nanoparticles. The SERS assay was able to monitor a five minute 
competitive binding event initiated by the presence of 15 pmols bisphenol A in free solution. However, detailed 
characterization of the dose-response relationship and coefficients of variation of the system will assist in further 
development of this molecular recognition platform. Additionally, this approach has the potential to be translated to any 
aptamer/antigen pair and provides the added benefit of magnetic manipulation of the nanoparticle sensing network. 
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